Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.
Hassanein, Tarek, Craig J McClain, Vatsalya Vatsalya, Lance L Stein, Steven L Flamm, Paul Martin, Matthew C Cave, et al. 2024. “Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.”. The American Journal of Gastroenterology 119 (1): 107-15.